Global Oxaliplatin Market Growth (Status and Outlook) 2023-2029

Global Oxaliplatin Market Growth (Status and Outlook) 2023-2029

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.



In this report, only the finished drug is covered, exclude API.

LPI (LP Information)' newest research report, the “Oxaliplatin Industry Forecast” looks at past sales and reviews total world Oxaliplatin sales in 2022, providing a comprehensive analysis by region and market sector of projected Oxaliplatin sales for 2023 through 2029. With Oxaliplatin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oxaliplatin industry.

This Insight Report provides a comprehensive analysis of the global Oxaliplatin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oxaliplatin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oxaliplatin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oxaliplatin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oxaliplatin.

The global Oxaliplatin market size is projected to grow from US$ 878 million in 2022 to US$ 1629.1 million in 2029; it is expected to grow at a CAGR of 9.2% from 2023 to 2029.

Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Oxaliplatin market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Mannitol
Glucose Solution
Lactose Solution
Others

Segmentation by application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing

Please note: The report will take approximately 2 business days to prepare and deliver.